| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 8259327
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1
- Deadline: 10 May 2026
- Ref No: 8260726
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg
- Deadline: 10 May 2026
- Ref No: 5306291
- Location: Germany
Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01
- Deadline: 05 Apr 2026
- Ref No: 5304038
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Pemetrexed Atc L01Ba04
- Deadline: 16 Apr 2026
- Ref No: 5301821
- Location: Bulgaria
Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad
- Deadline: 27 May 2027
- Ref No: 5310172
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Bortezomib Atc L01Xg01
- Deadline: 16 Apr 2026
- Ref No: 5396790
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
- Ref No: 5975224
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred
- Deadline: 30 Apr 2026
- Ref No: 5226107
- Location: Germany
Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08
- Deadline: 31 Mar 2026
- Ref No: 5227518
- Location: Germany
Medicines With The Active Ingredient Tiotropium Bromide Atc R03Bb04 Except In The Dosage Form Hard Capsules With Powder For Inhalation
- Deadline: 31 Mar 2026
- Ref No: 5976401
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf
- Deadline: 10 May 2026
- Ref No: 5965319
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi
- Deadline: 10 May 2026
- Ref No: 5968352
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage
- Deadline: 10 May 2026
